Navigation Links
XTENT Announces Fourth Quarter 2008 Financial Results and Business Progress
Date:2/19/2009

the results predicted and which are included in the "Risk Factors" section of XTENT's most recent quarterly report on Form 10-Q for the quarter ended September 30, 2008. This quarterly report was filed with the SEC on November 12, 2008, and is available on the company's investor relations website at http://www.xtentinc.com and on the SEC's website at http://www.sec.gov. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. XTENT undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.



                                 XTENT, INC.
                        (a development stage company)
                      Condensed Statements of Operations
             (unaudited; in thousands, except per share amounts)

                                        Three Months Ended      Year Ended
                                           December 31,        December 31,
                                          2008      2007      2008      2007
    Operating expenses:
      Research and development (1)       $5,252    $9,194   $31,170   $30,888
      General and administrative (1)      1,965     3,375    10,917    11,269
        Total operating expenses          7,217    12,569    42,087    42,157

    Loss from operations                 (7,217)  (12,569)  (42,087)  (42,157)

    Interest and other income, net          104       705       966     3,363

    Net loss                            $(7,113) $(11,864) $(41,121) $(38,794)

    Net loss per share - basic and
     diluted                             $(0.31)   $(0.52)   $(1.78)   $(1.87)

    Weighted-average common shares
     outstanding used in per share
     calcul
'/>"/>
SOURCE XTENT, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. XTENT Announces Third Quarter 2007 Financial Results
2. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
3. XTENT Announces 2007 Financial Results Conference Call
4. New study shows extent of harmful human influences on global ecosystems
5. XTENT Announces 2007 Financial Results
6. XTENT to Present at Cowen and Companys 28th Annual Health Care Conference
7. XTENT Announces CUSTOM I Data Receives Recognition from EuroIntervention
8. XTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors
9. XTENT Announces Second Quarter 2008 Financial Results and Business Progress
10. XTENT Announces Third Quarter 2008 Financial Results
11. APIC Covers Up Extent and Causes of Deadly C. diff
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Obispo, CA (PRWEB) November 26, 2014 ... is offering lower prices in an early celebration of ... Bunion Booties are being offered at the promotional price ... promotional pricing is in addition to any automatic discounts ... the Bunion Bootie website for complete details. ...
(Date:11/26/2014)... News Facts , Lexmark’s ... RSNA 2014 in Chicago. The company will demonstrate ... images, photos, videos and documents found throughout the ... learn more about these innovative medical content management ... initiatives – that enable more informed clinical decisions, ...
(Date:11/26/2014)... -- Youngsters who enter puberty early are at increased ... puberty was linked with a number of factors associated ... levels, according to the researchers. Early puberty was also ... and peers, and having friends who were prone to ... study found an association between early puberty and these ...
(Date:11/26/2014)... -- The number of emergency department visits in the United ... record 136 million in 2011, according to the U.S. Centers ... that fewer people were going to ERs with non-urgent medical ... care within two hours of arriving at the ER. In ... Sixty percent of patients arrived at the ER after ...
(Date:11/26/2014)... HealthDay Reporter TUESDAY, Nov. 25, ... Nexium may disrupt the makeup of bacteria in the digestive ... a small new study suggests. The research doesn,t ... become ill, and study authors aren,t recommending that anyone stop ... "should be used at the lowest dose that provides adequate ...
Breaking Medicine News(10 mins):Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:ER Visits on the Rise, Study Reports 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 3
... in the pancreas, but in the brain as well. When ... can be brain cell death and subsequent development of the ... was conducted in rats, and it was identified that insulin ... produced in the nerve cells, neurons in several brain regions. ...
... of the International Association for Dental Research held in ... a study// that says eating sugar-free yogurt is good ... odor or so called bad breath is caused by ... study revealed that volunteers who had sugar-free more and ...
... in the juice of pomegranate may help in reducing ... process of plaques etc forming in the inner lining ... state of atherosclerosis. This causes disturbed blood flow and ... the risk of atherogenesis. ,The new study ...
... has found out that depression has to be blamed for ... to treat the same. The study was conducted on 60,000 ... results showed both the newer and older classes of antidepressants ... first month of being prescribed.The older class of tricyclic antidepressants ...
... Diabetes Care, March 2005, scientists have reported that caffeine may ... the measure for the risk of heart disease. If a ... risk of heart problems. ,Diabetes type 2 happens when ... As this happens the body becomes unable to produce enough ...
... administration of the drug tezosentan did not improve worsening heart ... // despite high hopes. The above fact was found out ... date. The study was conducted to evaluate if something more ... to speed up hospital discharge and prevent them from coming ...
Cached Medicine News:
(Date:11/26/2014)... China , Nov. 26, 2014 / -- China Nepstar Chain ... "Company"), a leading retail drugstore chain in ... operated stores, today announced the appointment of Ms. ... Officer, effective immediately. Ms.Zhang has over ... joined Nepstar in March 1999. Prior to Ms. Zhang,s ...
(Date:11/24/2014)... 24, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... corporate overview and update at the Piper Jaffray 26 th ... 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time), at The ... . A live audio webcast of the presentation ... website at www.arenapharm.com . A replay of the presentation ...
(Date:11/24/2014)... Luoxis Diagnostics, Inc., a subsidiary of ... the presentation of three clinical and preclinical studies ... applicable and robust research tool capable of measuring ... to injury, illness, or stress.  In all three ... academic and pharmaceutical research partners, RedoxSYS was able ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 2China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 3Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 2Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 4Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 5
... SAN DIEGO, Nov. 16 CareFusion (NYSE: ... announced a Web-based application that provides hospitals with on-demand ... costs. , The CareFusion Knowledge Portal is a remotely ... information dashboard to review metrics and actionable data directly ...
... Nov. 16 Personalized Pharmaceutical Systems (PPS) today announced ... Viropharma Incorporated. , PPS is a clinical trial ... technology in phenomics to help drug companies identify the ... help patients get the right drug the first time. ...
Cached Medicine Technology:CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms 2CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms 3Personalized Pharmaceutical Systems Announces Sale of Angioedema Clinical Prediction Guide to Viropharma Incorporated 2
... Helmer PC1200 Platelet Incubators ... your laboratory counter top. These ... institution to have the security ... environment without taking up a ...
The PC4200i is the largest capacity platelet incubator available. It features a built-in agitator with a capacity of 396 random bags (132 apheresis)....
... Platelet incubators hold rotators and ... temperature can be set at ... 15C to 40C (59F to ... from top to bottom. Recorder ...
An enzyme-linked immuno-sorbent assay for the detection and quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Medicine Products: